Avocado Soybean Unsaponifiables Lipoic Acid Oral Composition

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for managing inflammation in joint tissues, such as osteoarthritis, often rely on non-steroidal anti-inflammatory drugs (NSAIDs) that can have adverse side effects and impair bone healing and repair.

Innovation Solution

The administration of avocado/soybean unsaponifiables (ASU) and lipoic acid or its derivatives, either alone or in combination, to reduce levels of inflammatory mediators and promote connective tissue health.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If NSAIDs are used to manage inflammation in joint tissues, then inflammation is reduced, but adverse side effects occur and bone healing is impaired

Engineering Contradiction:

ImproveinflammationVSAvoidadverse side effects and impaired bone healing

Core Design Contradiction:

Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effects of traditional NSAIDs into beneficial effects by using natural products (avocado/soybean unsaponifiables and lipoic acid) that reduce inflammation without causing adverse side effects or impairing bone healing. The natural compounds inhibit pro-inflammatory mediators while preserving bone repair mechanisms.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the chemical parameters of anti-inflammatory treatment by replacing synthetic NSAIDs with natural compounds having different molecular structures and mechanisms of action. This parameter change results in reduced inflammation without the harmful side effects associated with traditional NSAIDs.

Inventive Principle:

Principle #35Parameter changes

2Object-affected harmful factors

If traditional anti-inflammatory drugs are administered, then inflammatory mediators are reduced, but connective tissue health is compromised

Engineering Contradiction:

Improveinflammatory mediatorsVSAvoidconnective tissue health

Core Design Contradiction:

Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent transforms the harmful impact of conventional anti-inflammatories on connective tissue into a beneficial outcome by employing natural products that selectively reduce inflammatory mediators while protecting and promoting connective tissue health through mechanisms involving cartilage synthesis and repair.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent introduces natural intermediaries (avocado/soybean unsaponifiables and lipoic acid) that mediate between inflammation reduction and connective tissue protection. These intermediaries inhibit pro-inflammatory pathways while simultaneously supporting connective tissue maintenance and repair.

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS20250152554A1Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration

Publication Date: 2025.05.15 NUTRAMAX LABORATORIES INC

AI summary

An orally administrable composition for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue includes a synergistic combination of: (i) avocado/soybean unsaponifiables; and (ii) lipoic acid, or a salt or derivative thereof. Methods for treating or reducing damage to connective tissue, for treating or reducing inflammatory symptoms associated with damage to connective tissue, or for reducing levels of one or more inflammatory mediators in connective tissue include administering the orally administrable composition to an avian or mammalian subject.